TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2025
Back to search
Official data from USPTO
NITYR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NITYR
ST13
US500000087604011Class
5, 35, 44
Filing
87604011
Registration
5716643
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
07/23/2025
Trademark type
Word
Nice classes
5, 35, 44
Filing date
09/11/2017
Registration date
04/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2025
Last transaction
07/23/2025
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/01/2017
First use in commerce
08/01/2017
Drawing code
4
Owner type
03
Owner location
Cambridge, GB
Examiner
BELENKER, ESTHER
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cycle Pharmaceuticals Ltd.
Representatives
Jaclyn Elizabeth Diffley STOBBS
Technical classification
Nice Classes
Class 5Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
(Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive systempharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive systempharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive systempharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparationsantioxidants; veterinary preparations namelypain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive systemsupplements for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; biological preparations for the treatment of disorders of the metabolism and digestive systembiological preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive systemchemical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsdrug delivery agents for use in pharmaceuticalsdrugs and medicines for the treatment of disorders of the metabolism and digestive systemdrug delivery agents for use in pharmaceuticalsdrugs and medicines for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; drugs for the treatment of rare diseasesin particular for the treatment of disorders of the metabolism and digestive systemdrugs for the treatment of rare diseasesin particular for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; enzyme preparations for medical purposesenzyme preparations for the treatment of disorders of the metabolism and digestive systemenzyme preparations for the treatment of tyrosinemia and hypertyrosinemiamedical enzyme preparations in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systemsmedical preparations for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; medicines for the treatment of disorders of the metabolism and digestive systemmedicines for the treatment of tyrosinemia and hypertyrosinemiaall in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches
Class 35
(Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticalsmedicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticalsmedicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticalsmedicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticalsmedicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticalsmedicines and supplements in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches
Class 44
(Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticalsmedicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticalsmedicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticalsmedicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticalsmedicines and supplements; dispensing of pharmaceuticalsmedicines and supplements in the form of liquidssolutionssuspensionssyrupsdropscapsulestabletscapletspowderscompressed tabletsdispersibilesvaporsgasesmistscreamsgels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medicalpharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medicalpharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medicalpharmacological and pharmaceutical testing services in relation to rare diseases; medicalpharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medicalpharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases
Publications
History of USPTO decisions and trademark events.
64 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/16/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/16/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/21/2025
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/15/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/16/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/23/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/15/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/28/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/27/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/26/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/15/2019
GNRT
NON-FINAL ACTION E-MAILED
02/15/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/15/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/14/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/14/2019
IUAF
USE AMENDMENT FILED
01/23/2019
EISU
TEAS STATEMENT OF USE RECEIVED
01/23/2019
NOAC
CORRECTED NOA E-MAILED
01/17/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/04/2018
PUBO
PUBLISHED FOR OPPOSITION
09/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/15/2018
DOCK
ASSIGNED TO EXAMINER
08/10/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/01/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/27/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/24/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/13/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/12/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/29/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/27/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/27/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/27/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/27/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2018
GNRT
NON-FINAL ACTION E-MAILED
05/01/2018
CNRT
NON-FINAL ACTION WRITTEN
05/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2018
ALIE
ASSIGNED TO LIE
04/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/14/2017
GNRT
NON-FINAL ACTION E-MAILED
12/14/2017
CNRT
NON-FINAL ACTION WRITTEN
12/14/2017
DOCK
ASSIGNED TO EXAMINER
12/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2017
NWAP
NEW APPLICATION ENTERED
09/14/2017
Continuous trademark protection
Get notified about every new filing that threatens NITYR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.